Impaired Fracture Healing Caused by Deficiency of the Immunoreceptor Adaptor Protein DAP12
暂无分享,去创建一个
[1] J. Kanis,et al. Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] P. Kostenuik,et al. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. , 2012, Clinical therapeutics.
[3] M. McDonald,et al. Characterization of the bone phenotype and fracture repair in osteopetrotic Incisors absent rats , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[4] Klaus Klaushofer,et al. Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] M. Matos,et al. The effect of zoledronate during bone healing , 2010, Journal of Orthopaedics and Traumatology.
[6] Thomas A Einhorn,et al. TNF-α Mediates Diabetes-Enhanced Chondrocyte Apoptosis During Fracture Healing and Stimulates Chondrocyte Apoptosis Through FOXO1 , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] Aaron Schindeler,et al. Bone remodeling during fracture repair: The cellular picture. , 2008, Seminars in cell & developmental biology.
[8] Tamara Sztynda,et al. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. , 2008, Bone.
[9] R. Faccio,et al. PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. , 2006, The Journal of clinical investigation.
[10] Lynne E Bilston,et al. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[11] Eric Vivier,et al. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions , 2005, European journal of immunology.
[12] M. Ulrich-Vinther,et al. Osteoprotegerin Treatment Impairs Remodeling and Apparent Material Properties of Callus Tissue without Influencing Structural Fracture Strength , 2005, Calcified Tissue International.
[13] S. Komatsubara,et al. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. , 2005, Bone.
[14] D. Graves,et al. Tumor necrosis factor alpha (TNF-α) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing , 2005 .
[15] H. Rubash,et al. Osteoblast proliferation and maturation by bisphosphonates. , 2004, Biomaterials.
[16] Jill A. Helms,et al. Altered fracture repair in the absence of MMP9 , 2003, Development.
[17] D. Graves,et al. Impaired Fracture Healing in the Absence of TNF‐α Signaling: The Role of TNF‐α in Endochondral Cartilage Resorption , 2003 .
[18] E. Schwarz,et al. Effects of receptor activator of NFκB (RANK) signaling blockade on fracture healing , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[19] K. Väänänen,et al. Long-Term Administration of Clodronate Does Not Prevent Fracture Healing in Rats , 2003, Clinical orthopaedics and related research.
[20] K. Tan-Takeuchi,et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. , 2003, The Journal of clinical investigation.
[21] M. Westmore,et al. Raloxifene, Estrogen, and Alendronate Affect the Processes of Fracture Repair Differently in Ovariectomized Rats , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] S. Hayashi,et al. Heterogeneity of presenile dementia with bone cysts (Nasu–Hakola disease):: Three genetic forms , 2002, Neurology.
[23] L. Peltonen,et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. , 2002, American journal of human genetics.
[24] G. Rodan,et al. Bisphosphonate mechanism of action , 2002, Current molecular medicine.
[25] S. Cummings,et al. Epidemiology and outcomes of osteoporotic fractures , 2002, The Lancet.
[26] T A Einhorn,et al. Expression of Osteoprotegerin, Receptor Activator of NF‐κB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[27] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[28] J. Li,et al. Long‐Term Effect of Incadronate Disodium (YM‐175) on Fracture Healing of Femoral Shaft in Growing Rats , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] Keisuke Sato,et al. The Role of the DAP12 Signal in Mouse Myeloid Differentiation1 , 2000, The Journal of Immunology.
[30] Jiliang Li,et al. Concentration of Bisphosphonate (Incadronate) in Callus Area and Its Effects on Fracture Healing in Rats , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[31] Leena Peltonen,et al. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts , 2000, Nature Genetics.
[32] J. Li,et al. Effect of Bisphosphonate (Incadronate) on Fracture Healing of Long Bones in Rats , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] Gabriele Bergers,et al. MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.
[34] T A Einhorn,et al. The expression of cytokine activity by fracture callus , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[35] J. Ravetch,et al. FcR γ chain deletion results in pleiotrophic effector cell defects , 1994, Cell.
[36] E Y Chao,et al. Internal remodeling of periosteal new bone during fracture healing , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[37] L.,et al. Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[38] D. Graves,et al. Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. , 2005, Bone.
[39] T A Einhorn,et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[40] J. Ravetch,et al. FcR gamma chain deletion results in pleiotrophic effector cell defects. , 1994, Cell.
[41] T. Einhorn,et al. Production of a standard closed fracture in laboratory animal bone , 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.